The strategic partnership will encompass a range of collaborations, initiatives and projects, drawing on the experience, ...

The two OTT platforms, JioCinema and Disney+ Hotstar have merged together to form a new platform JioHotstar, said a press ...

Albilad Capital, GIB Capital, AlRajhi Capital and Alinma Investment have been appointed as Co-underwriters. Lazard Saudi ...

TuHURA Biosciences, Inc. (Nasdaq:HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome primary and acquired resistance to cancer immunotherapy, two of ...

Chuck Ward, currently President, Sales, Marketing and Distribution, has been appointed to the newly created role of Executive ...

Recent research takes aim at the a variant in gene SCN1B, which causes a severe form of developmental epileptic encephalopathy.

should be given on a Supplemental Form 8 (Open Positions). Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a ...

Mr. Hébert will bring extensive expertise in regulatory affairs, law, government relations, and strategic business management to the Company’s Board of Directors ...

Researchers developed a new system for turning used coffee grounds into a paste, which they use to 3D print objects, such as packing materials and a vase. They inoculate the paste with Reishi mushroom ...

should be given on a Supplemental Form 8 (Open Positions). Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid. If approved, Dupixent would be the first and only targeted medicine to treat BP in ...